Growth Metrics

Emergent BioSolutions (EBS) Finished Goods (2016 - 2018)

Emergent BioSolutions has reported Finished Goods over the past 8 years, most recently at $50.8 million for Q4 2018.

  • For Q4 2018, Finished Goods rose 68.77% year-over-year to $50.8 million; the TTM value through Dec 2018 reached $50.8 million, up 68.77%, while the annual FY2018 figure was $50.8 million, 68.77% up from the prior year.
  • Finished Goods for Q4 2018 was $50.8 million at Emergent BioSolutions, up from $27.1 million in the prior quarter.
  • Over five years, Finished Goods peaked at $50.8 million in Q4 2018 and troughed at $6.9 million in Q4 2015.
  • A 5-year average of $23.0 million and a median of $23.9 million in 2015 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: skyrocketed 669.76% in 2014 and later tumbled 58.88% in 2017.
  • Year by year, Finished Goods stood at $14.8 million in 2014, then plummeted by 53.43% to $6.9 million in 2015, then soared by 240.34% to $23.5 million in 2016, then increased by 28.12% to $30.1 million in 2017, then surged by 68.77% to $50.8 million in 2018.
  • Business Quant data shows Finished Goods for EBS at $50.8 million in Q4 2018, $27.1 million in Q3 2018, and $25.4 million in Q2 2018.